Clinical Study

Fig fruit extract promising for sugar metabolism

Format: PDF file | Document type: Clinical Study | Promoted Content

This Clinical Study has been written by Euromed S.A. , and any views and opinions expressed do not necessarily reflect those of www.nutraingredients-usa.com

Fig fruit extract promising for sugar metabolism

A randomized, double-blind crossover study investigated metabolic adaptogen properties of abscisic acid (ABA), a novel naturally occurring compound. Test food was a fig fruit extract (ABAlife®​) standardized for two ABA concentrations. Post prandial glucose and insulin responses were tested in 10 healthy participants. Results indicate ABAlife®​, in relatively small doses (100-200mg), can produce significant and clinically relevant reductions in postprandial glucose and insulin responses and may be a promising ingredient for natural management of glucose homeostasis and metabolic disorders.

Related resources from Euromed S.A.

Supplier info centre